Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!
  Get the Manual of Investments on Amazon!
Subscribe

UNITED STATES
Zymeworks secures $250M funding with royalty-backed note
2026-03-02
UNH
UnitedHealth Group Inc. Reports $568M Net Gain in Q4 2025
2026-03-02
UTILITIES
Venture Global Reports 192% Revenue Increase
2026-03-02
UNITED STATES
HEALTH CARE
RYTM
Rhythm Pharmaceuticals Reports Positive Data on Setmelanotide
Rhythm Pharmaceuticals, Inc. has released additional positive data from its global phase 3 trial of Setmelanotide in patients with acquired hypothalamic obesity (HO). The new data set includes 12 patients from a Japanese cohort and 10 supplemental patients who were enrolled in addition to the primary 120-patient pivotal cohort. The key highlights from the 52-week data include an -18.8% placebo-adjusted difference in BMI reduction for all patients, with a primary endpoint of mean BMI...
Monday, March 02
Market Inference Newsletter
TOP STORIES
United Therapeutics Announces Positive Results for Ralinepag in PAH Study
United Therapeutics Corporation (NASDAQ: UTHR) has announced the significant results of its long-term pivotal phase 3 Advance Outcomes study,...
Bandwidth Repurchases $100M in Convertible Notes
Bandwidth Inc. (NASDAQ: BAND) has announced a partial repurchase of its 0.50% convertible senior notes due 2028. The company has entered into...
Eaton Corp Appoints David Foster as CFO
Eaton (NYSE: ETN) has announced the appointment of David Foster as its new Executive Vice President and Chief Financial Officer, effective March...
Malibu Boats, Inc. Acquires Saxdor Yachts for $175 Million
Malibu Boats, Inc. has announced the acquisition of Saxdor Yachts, a leading European designer and manufacturer of premium adventure dayboats, for...

Market Trends

KOS
UNITED STATES
ENERGY
Kosmos Energy Reports $377M Net Loss
Kosmos Energy Ltd. has released its financial and operating results for the fourth quarter of 2025, revealing a net loss of $377 million, or $0.79...
Monday, March 02
Norwegian Cruise Line Reports $9.8B Revenue in 2025
UNITED STATES
Eton Pharmaceuticals Acquires U.S. Rights to Hemangeol®
HEALTH CARE
Positive Phase 1 Results for SEPN's Oral GPCR Medicine
SEPN
Civista Bancshares, Inc. Names Chuck Parcher as New President and CEO
CIVB
RadNet Reports Record Revenue and EBITDA Gains
HEALTH CARE
ADT Reports $5.1B Revenue for 2025
UNITED STATES
AAON Reports Record Backlog for 2026
UNITED STATES
EYPT
UNITED STATES
INDUSTRIALS
EyePoint Doses First Patients in Phase 3 Trials for Duravyu™
Eyepoint, Inc. (NASDAQ: EYPT) has announced that it has dosed the first patients in both global...
Monday, March 02
Adma Biologics Announces $200M Capital Return Initiative
ADMA
AES Corporation Acquired for $10.7 Billion
UNITED STATES
uniQure Reports $622.5M Cash Holdings in 2025
QURE
Xeris Biopharma Reports Record-Breaking Financial Performance
XERS
Encore Energy Founder Retires, Becomes Verdera Energy Chair
BASIC MATERIALS
Sionna Therapeutics Reports Strong Cash Position and Pipeline Updates
SION
Astrana Health Sees 56% Revenue Surge
ASTH
Popular
Geron Corp's RYTELO Commercial Launch and Market Authorizations
Sealed Air Corp Reports Q4 Sales Increase
STEVEN MADDEN (SHOO) 10-K Report Overview
Apogee Therapeutics Boosts Cash Reserves to $902.9M
Company X Reports 25% Revenue Increase and 42.8% Profit Growth
Dyne Therapeutics Reports $1.1B Cash Position
DBV Technologies Shares Surge 10.53%
Preminium Access

In Focus

Monday, March 02
Tegna Inc. Reports 19% Revenue Drop in Q4 2025
Monday, March 02
Millrose Properties Releases 10-K Report
Monday, March 02
Farmers National Banc Corp. merges with Middlefield Banc Corp., adding $7.4 billion in assets
Monday, March 02
Monopar Therapeutics Appoints Susan Rodriguez as Chief Commercial Officer
Monday, March 02
UroGen Pharma's Focus on Innovative Cancer Solutions
Monday, March 02
Sabre Corporation Adopts Shareholder Rights Plan
Monday, March 02
Intellia Therapeutics Increases Market Sale Agreement by Over $1 Billion
Monday, March 02
Turning Point Brands Reports 266% Surge in Modern Oral Sales